Human papillomavirus type 33 infection

Human papillomavirus type 33 infection has been studied in 1 paper since 2025: 1 observational study in people; 1 in the past year. The newest paper, Dec 16, 2025: “Factors related to cervicogenital high-risk human papillomavirus persistence among Chinese women: a nationwide multi-center cohort study”.

Exposure

1 paper studies it1 findingUpdated

See all 1 papers on human papillomavirus type 33 infection

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Infection with HPV33 (OR = 2.40, 95% CI: 1.42-4.01)”
Factors related to cervicogenital high-risk human papillomavirus persistence among Chinese women: a nationwide multi-center cohort studyVirology journal2025doi:10.1186/s12985-025-03047-4
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: National Natural Science Foundation of China and 1 more
  • Humans1

What is human papillomavirus type 33 infection linked with?

1

Studies link human papillomavirus type 33 infection with 3-year HR-HPV persistence.

3-year HR-HPV persistence

upin humans1OR 2.4

1 study
  1. Human papillomavirus type 33 infection is associated with 3-year HR-HPV persistence in humans (HR-HPV positive at baseline) (OR 2.40, 95% CI 1.42–4.01).

    “Infection with HPV33 (OR = 2.40, 95% CI: 1.42-4.01)”

    HumansHR-HPV positive at baseline3 yearsfemalesn = 1,684

    Factors related to cervicogenital high-risk human papillomavirus persistence among Chinese women: a nationwide multi-center cohort study

    Virology journal

More on 3-year HR-HPV persistence

Latest

Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months